Why Bank of America expects the hot European pharmaceuticals sector to stumble — and it’s not a fear of U.S. drug prices
January 07, 2020 at 07:26 AM EST
Bank of America expects European stocks broadly to rise this year, but its key underweight call is the pharmaceutical sector, and the recommendation has nothing to do with talk of reining in U.S. drug prices.